Jeffrey S. Glenn

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Jeffrey S. Glenn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey S. Glenn:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. Director Common Stock 182,355 $54,287 $0.2977 22 Dec 2022 Direct
Eiger BioPharmaceuticals, Inc. Director Common Stock 151,064 $44,972 $0.2977 22 Dec 2022 By Eiger Group International, Inc.
Eiger BioPharmaceuticals, Inc. Director Common Stock 5,000 $1,489 $0.2977 22 Dec 2022 By spouse
Eiger BioPharmaceuticals, Inc. Director Common Stock 460 $137 $0.2977 22 Dec 2022 By son
Eiger BioPharmaceuticals, Inc. Director Stock Option (Right to Buy) 28,000 01 Mar 2023 Direct

Insider Reports Filed by Jeffrey S. Glenn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000114036123010161-glenn-jeffrey-s-2023-03-01 Eiger BioPharmaceuticals, Inc. 01 Mar 2023 1 $0 4 Director 03 Mar 2023, 19:50
/report/000114036122047070-glenn-jeffrey-s-2022-12-22 Eiger BioPharmaceuticals, Inc. 22 Dec 2022 1 +$127,950 4 Director 27 Dec 2022, 16:31
/report/000114036122009259-glenn-jeffrey-s-2022-03-11 Eiger BioPharmaceuticals, Inc. 11 Mar 2022 2 $0 4 Director 11 Mar 2022, 20:06